Neville Rodie & Shaw Inc. Has $35.72 Million Stock Position in Lam Research Corporation $LRCX

Neville Rodie & Shaw Inc. trimmed its holdings in shares of Lam Research Corporation (NASDAQ:LRCX) by 15.2% in the 3rd quarter, Holdings Channel.com reports. The firm owned 266,754 shares of the semiconductor company’s stock after selling 47,688 shares during the period. Lam Research makes up approximately 2.6% of Neville Rodie & Shaw Inc.’s portfolio, making the stock its 8th largest holding. Neville Rodie & Shaw Inc.’s holdings in Lam Research were worth $35,718,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Sava Infond d.o.o. lifted its stake in shares of Lam Research by 3.1% during the 2nd quarter. Sava Infond d.o.o. now owns 75,250 shares of the semiconductor company’s stock worth $7,325,000 after acquiring an additional 2,250 shares during the last quarter. Horizon Bancorp Inc. IN purchased a new position in shares of Lam Research during the second quarter valued at $389,000. Empowered Funds LLC raised its holdings in shares of Lam Research by 10.5% in the first quarter. Empowered Funds LLC now owns 187,472 shares of the semiconductor company’s stock valued at $13,629,000 after acquiring an additional 17,833 shares in the last quarter. Genus Capital Management Inc. purchased a new stake in Lam Research in the second quarter worth about $14,476,000. Finally, Glass Wealth Management Co LLC grew its holdings in Lam Research by 8.5% during the 2nd quarter. Glass Wealth Management Co LLC now owns 28,870 shares of the semiconductor company’s stock worth $2,810,000 after acquiring an additional 2,270 shares in the last quarter. 84.61% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Lam Research news, Director Bethany Mayer sold 1,298 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total value of $207,667.02. Following the sale, the director directly owned 1,652 shares of the company’s stock, valued at approximately $264,303.48. This trade represents a 44.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Douglas R. Bettinger sold 40,080 shares of the business’s stock in a transaction that occurred on Friday, November 14th. The shares were sold at an average price of $150.60, for a total value of $6,036,048.00. Following the completion of the sale, the chief financial officer owned 987,237 shares of the company’s stock, valued at $148,677,892.20. This trade represents a 3.90% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 102,608 shares of company stock worth $14,916,496 in the last 90 days. 0.31% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several analysts have issued reports on the company. The Goldman Sachs Group increased their target price on Lam Research from $115.00 to $160.00 and gave the company a “buy” rating in a research report on Wednesday, October 8th. BNP Paribas Exane raised their price target on shares of Lam Research from $80.00 to $140.00 and gave the stock a “neutral” rating in a report on Thursday, October 23rd. Berenberg Bank raised their target price on Lam Research from $122.00 to $165.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Jefferies Financial Group reaffirmed a “buy” rating and set a $200.00 price target on shares of Lam Research in a research report on Monday. Finally, Mizuho raised their target price on shares of Lam Research from $162.00 to $170.00 and gave the stock an “outperform” rating in a report on Thursday, October 23rd. Twenty-six analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to MarketBeat.com, Lam Research currently has a consensus rating of “Moderate Buy” and a consensus target price of $156.21.

Lam Research Price Performance

NASDAQ:LRCX opened at $160.52 on Monday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60. The company has a 50 day moving average price of $152.53 and a 200-day moving average price of $120.50. Lam Research Corporation has a 1-year low of $56.32 and a 1-year high of $169.69. The firm has a market cap of $201.62 billion, a price-to-earnings ratio of 35.36, a price-to-earnings-growth ratio of 1.65 and a beta of 1.77.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.22 by $0.04. The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The firm’s quarterly revenue was up 27.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.86 earnings per share. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Equities research analysts forecast that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be given a dividend of $0.26 per share. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.6%. Lam Research’s dividend payout ratio (DPR) is 22.91%.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.